Latest Breaking News On - Pasadena based arrowhead pharmaceuticals - Page 1 : comparemela.com

Shares Up Mostly - San Fernando Valley Business Journal

Although the stock markets overall enjoyed a banner year in 2023 – the S&P 500 was up 24% – Valley-area stocks, with a few notable exceptions, had a far more modest year.

Los angelesRick barraganSanta monicaBbob igerSahak manuelianNelson peltzArrowhead pharmaceuticals incAtara biotherapeutics incFederal reserveSemtech corpMannkind corpArcutis biotherapeutics incAmgen incNetsol technologies incSimulations plus incWalt disney co

Stock Market Rebounds - Los Angeles Business Journal

LA-based public companies ended 2023 strong.

Evan spiegelNelson peltzRick barraganSahak manuelianBbob igerLos angelesSanta monicaVirco manufacturing corpJoe scarnici getty images for snap incWalt disney coWestwood puma biotechnology incFederal reserveAmgen incPennymac financial services incImmunitybio incArrowhead pharmaceuticals inc

Arrowhead Drugs Progress - Los Angeles Business Journal

Pasadena-based Arrowhead Pharmaceuticals Inc. in recent weeks has notched significant progress with clinical trials of drugs developed from its platform that turns off genes that can trigger diseases.

Lou gehrigChris anzaloneDrug administrationTakeda pharmaceutical coArrowhead pharmaceuticals incPasadena based arrowhead pharmaceuticalsSan martin

Arrowhead Licensing Deals Pay Off with $70M in Milestone Payments - Los Angeles Business Journal

Learn more about Arrowhead Pharmaceuticals receiving two payments this month (April) totaling $70 million for milestones achieved for two drug candidates that it licensed out to other major pharmaceutical companies.

Christopher anzaloneArrowhead pharmaceuticals incTakeda pharmaceuticalsJanssen pharmaceuticalsAmgen incPasadena based arrowhead pharmaceuticalsJapan based takeda pharmaceuticalsThousand oaks based amgen incNew jersey based janssen pharmaceuticalsChief executive christopher anzaloneNew jersey based johnsonGreater chinaArrowhead chief executive christopher anzalone

Arrowhead Sells Royalty Interest in Heart Disease Treatment Drug for $250M Plus

Arrowhead Sells Royalty Interest in Heart Disease Treatment Drug for $250M Plus
labusinessjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labusinessjournal.com Daily Mail and Mail on Sunday newspapers.

Amgen incArrowhead pharmaceuticals incPasadena based arrowhead pharmaceuticalsNew york basedRoyalty pharmaThousand oaks based amgen